Dazostinag clinical trials
Includes 2 studies of Dazostinag sodium.
- studies test it
- 3
- open now
- 0
- in phase 3
- 0
- first study started
- 2020
How each study uses dazostinag is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
Studies by the year they started
3 studies that test it; most in 2021 (2)
| Year | Studies |
|---|---|
| 2020 | 1 |
| 2021 | 2 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 3 · Other 0
Studies
Open first, then newest update. How each study uses dazostinag is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 3
- A Study of Dazostinag as Single Agent and Dazostinag in Combination With Pembrolizumab in Adults With Advanced or Metastatic Solid TumorsCompletedPhase 1/2TakedaNCT04420884Written as DazostinagHow we know
- A Study of TAK-676 With Pembrolizumab After Radiation Therapy to Treat a Number of CancersCompletedPhase 1TakedaNCT04879849Written as TAK-676How we know
- PBI-MST-01(NCT04541108) Substudy TAK-02: Intratumoral Microdosing of TAK-676 in HNSCCCompletedEarly Phase 1Presage BiosciencesNCT06062602Written as TAK-676How we know
What changed recently
From the registry's own updates since Oct 20, 2026.
Results posted1
Codes
What other systems call dazostinag · ClinicalTrials.gg INT018306
- UNII (FDA) W4RT71M1YDDAZOSTINAGOne source FDA
- NCI Thesaurus C199200DazostinagOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | W4RT71M1YD | DAZOSTINAG | One source FDA |
| NCI Thesaurus | C199200 | Dazostinag | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.